19Indexed trials
mesh condition
Parkinsonian Disorders
Intelligence
Parkinsonian Disorders intelligence: 19 indexed trials, 7 recruiting studies, 19 sponsors across 12 countries.
7Recruiting
19Sponsors
12Countries
Leading sponsors
Adamas Pharmaceuticals, Inc.10 recruiting
Bastyr University11 recruiting
Beijing Friendship Hospital10 recruiting
California Pacific Medical Center Research Institute10 recruiting
Dartmouth-Hitchcock Medical Center10 recruiting
Federal University of Rio Grande do Sul10 recruiting
Fondazione Don Carlo Gnocchi ETS11 recruiting
National Heart, Lung, and Blood Institute (NHLBI)10 recruiting
Northwestern University10 recruiting
Queen Mary University of London11 recruiting
Ruijin Hospital11 recruiting
The Hong Kong Polytechnic University10 recruiting
Geographic activity
United States11trials
China2trials
Canada2trials
United Kingdom2trials
Austria1trials
Hong Kong1trials
Italy1trials
Spain1trials
Germany1trials
Belgium1trials
Brazil1trials
France1trials
Leading interventions
ADPM1trials
ADS-51021trials
Botulinum Neurotoxin Type A1trials
CUE1 non-invasive device1trials
CUE1+ device active vs sham CUE1+ device1trials
Current standard discharge educational intervention1trials
Dance Program1trials
GAITRite1trials
Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules1trials
Palliative Care1trials
Personalized discharge educational intervention1trials
Rozerem1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.